C12Y 303/02009
Microsomal epoxide hydrolase , i.e. styreneepoxide hydrolase
Official title: Microsomal epoxide hydrolase (3.3.2.9), i.e. styreneepoxide hydrolase
C12Y303/02009 (Microsomal epoxide hydrolase , i.e. styreneepoxide hydrolase) appears on 4 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 13
- Assignees
- 7
- Inventors
- 28
- Latest grant
- 30 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Synthetic methods30 Nov 2021US 11,186,558 B2Glaxosmithkline Intellectual Property (No.2) Limited
- Nucleic acids and proteins and methods for making and using them24 Feb 2015US 8,962,800 B2BP Corporation North America Inc.
- Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy14 Aug 2012US 8,242,170 B2The Regents of the University of California
- Nucleic acids and proteins and methods for making and using them21 Feb 2012US 8,119,385 B2BP Corporation North America Inc.
- Biosynthesis of mogrosides20 Jun 2024US 2024/0200114 A1Ginkgo Bioworks, Inc.
- Biosynthesis of mogrosides8 Jun 2023US 2023/0174993 A1Ginkgo Bioworks, Inc.
- Biosynthesis of mogrosides1 Dec 2022US 2022/0378072 A1Ginkgo Bioworks, Inc.
- Synthetic methods24 Feb 2022US 2022/0055999 A1Glaxosmithkline Intellectual Property (No.2) Limited
- Synthetic methods15 Oct 2020US 2020/0325110 A1Glaxosmithkline Intellectual Property (No.2) Limited
Most cited
By later US patents
- Nucleic acids and proteins and methods for making and using them18US 8,119,385 B2BP Corporation North America Inc. · 2012
- Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy3US 8,242,170 B2The Regents of the University of California · 2012
- Nucleic acids and proteins and methods for making and using them2US 8,962,800 B2BP Corporation North America Inc. · 2015